טוען...
Rituximab as Single Agent in Primary MALT Lymphoma of the Ocular Adnexa
Ocular Adnexal Lymphomas are the first cause of primary ocular malignancies, and among them the most common are MALT Ocular Adnexal Lymphomas. Recently systemic immunotherapy with anti-CD20 monoclonal antibody has been investigated as first-line treatment; however, the optimal management for MALT Oc...
שמור ב:
| הוצא לאור ב: | Biomed Res Int |
|---|---|
| Main Authors: | , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Hindawi Publishing Corporation
2015
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4575717/ https://ncbi.nlm.nih.gov/pubmed/26425558 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/895105 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|